Advertisement

Clinical Drug Investigation

, Volume 22, Issue 4, pp 263–268 | Cite as

Efficacy of Ipratropium Bromide Aqueous Nasal Spray in the Prevention of Nasal Secretion Induced by Inhaled Methacholine

  • A. Smeraldi
  • E. Crimi
  • M. Milanese
  • A. Rossetti
  • L. Cantini
  • V. Brusasco
Original Research Article
  • 13 Downloads

Abstract

Objective: The present study was conducted to assess if a new formulation of ipratropium bromide nasal spray could prevent the nasal hypersecretion induced by a whole nasal challenge with increasing doses of methacholine.

Patients and methods: Twenty adult outpatients with ongoing hypersecretive rhinitis were selected and, after a preliminary session without any pretreatment, randomised to receive a single dose of nasal aqueous ipratropium bromide 80μg and matched placebo administered via a metered pump 60 minutes before methacholine challenge on two consecutive days. In each session, methacholine was inhaled into the nostrils at four increasing concentrations of 1, 4, 16 and 64 mg/ml, at 20-minute intervals. The induced secretion was evaluated by weighing a cotton tampon placed in each nostril for 30 seconds following the methacholine stimulation; weights were adjusted for spontaneous secretion. In addition, an acoustic rhinometer was used to measure the change in resistance and volume of each nasal cavity.

Results: The nasal discharge (adjusted for pretreatment values) was significantly reduced after pretreatment with ipratropium bromide, both in the cumulative weight (p < 0.01) and at each methacholine concentration (p < 0.05 after 1 and 4 mg/ml, p < 0.01 after 16 and 64 mg/ml). No relevant changes in nasal patency were observed during the test without pretreatment, nor during the two treatment sessions; similarly, no significant differences were observed in the comparison between active drug and placebo for both resistance and volume.

Conclusions: The results of the present study demonstrate that an intranasal aqueous solution of ipratropium bromide reduces the nasal discharge induced by locally applied methacholine. No effects were seen in the parameters used to measure nasal congestion.

Keywords

Rhinitis Methacholine Ipratropium Bromide Nedocromil Nasal Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This study was sponsored by a grant from Chiesi Farmaceutici SpA, Parma, Italy.

References

  1. 1.
    Tos M. Goblet cells and glands in the nose and paranasal sinuses. In: Proctor DF, Andersen I, editors. The nose: upper airways physiologic and atmospheric environment. Amsterdam: Elsevier Biomedical, 1982: 99–162Google Scholar
  2. 2.
    Cauna N. Innervation of human nasal gland. J Neurocytol 1972; 1: 49–60PubMedCrossRefGoogle Scholar
  3. 3.
    Golding-Wood PH. Vidian neurectomy: its results and complications. Laryngoscope 1973; 83: 1673–83PubMedCrossRefGoogle Scholar
  4. 4.
    Naclerio RM, Baroody FM. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol 1995; 95: 1069–79PubMedCrossRefGoogle Scholar
  5. 5.
    Bronsky EA, Druce H, Finday SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial non-allergic rhinitis. J Allergy Clin Immunol 1995; 95: 1117–22PubMedCrossRefGoogle Scholar
  6. 6.
    Grossman J, Banov C, Boggs P. Use of ipratropium bromide nasal spray in chronic treatment of non allergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol 1995; 95: 1123–7PubMedCrossRefGoogle Scholar
  7. 7.
    Sanwikarja S, Schmitz PIM, Dieges PH. The effect of locally applied ipratropium aerosol on the nasal methacholine challenge in patients with allergic and non allergic rhinitis. Ann Allergy 1986; 56: 162–6PubMedGoogle Scholar
  8. 8.
    Baroody FM, Majchelam AM, Roecker MM, et al. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol 1992; 89: 1065–75PubMedCrossRefGoogle Scholar
  9. 9.
    Wagenmann M, Baroody FM, Jankowski R, et al. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exper Allergy 1994; 24: 288–90CrossRefGoogle Scholar
  10. 10.
    Hayden FG, Diamond L, Wood PB, et al. Effectiveness and safety of intranasal ipratropium bromide in common colds. Ann Intern Med 1996; 125: 89–97PubMedGoogle Scholar
  11. 11.
    Diamond L, Dockhorn RJ, Grossman J, et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 1995; 95: 1139–46PubMedCrossRefGoogle Scholar
  12. 12.
    Grymer LF. Clinical applications of acoustic rhinometry. Rhinol Suppl 2000; 16: 35–43PubMedGoogle Scholar
  13. 13.
    Baroody F, Naclerio RM. A comparison of response of the nasal mucosa to histamine and methacholine. Am Rev Respir Dis 1990; 141: 176Google Scholar
  14. 14.
    Cauna N. Blood nerve supply of the nasal lining. In: Proctor DF, Andersen I, editors. The nose: upper airway physiology and the atmospheric environment. Amsterdam: Elsevier Biomedical, 1982: 45–69Google Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  • A. Smeraldi
    • 1
  • E. Crimi
    • 1
  • M. Milanese
    • 1
  • A. Rossetti
    • 2
  • L. Cantini
    • 2
  • V. Brusasco
    • 1
  1. 1.Department of Motor SciencesUniversity of GenoaGenoaItaly
  2. 2.Medical DepartmentChiesi Group FarmaceuticiParmaItaly

Personalised recommendations